DuraHeart LVAS Clinical Trial Results Are Successful
DuraHeart LVAS Clinical Trial
Terumo Heart had a successful European Launch Symposium at the European Association of Cardio-Thoracic Surgeons (EACTS) meeting in Geneva, Switzerland.
A summary of the European Clinical Trial results for the DuraHeart Left Ventricular Assist System (LVAS) was presented by Dr. Aly El-Banayosy from the Heart Center Nordrhein-Westfalen in Bad Oeynhausen, Germany, followed by the presentation "The Emerging New Era of Mechanical Circulatory Support," by Dr. Eric Rose of Columbia University Medical Center in New York.
The symposium highlighted the DuraHeart device, as well as the BioValsalva Aortic Valved Conduit developed by Vascutek Ltd, a Terumo Company.
A summary of DuraHeart LVAS clinical results to-date (as of September 15, 2007):
* Patients enrolled = 33
* Median age (years) = 57 (29-73)
* Mean support duration (days) = 231